<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-43025" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Urticaria</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dabija</surname>
            <given-names>Dominique</given-names>
          </name>
          <aff>The Ohio State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tadi</surname>
            <given-names>Prasanna</given-names>
          </name>
          <aff>Asram Medical College, Eluru, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Danosos</surname>
            <given-names>Gerard N.</given-names>
          </name>
          <aff>Lake Erie College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dominique Dabija declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prasanna Tadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gerard Danosos declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-43025.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chronic spontaneous urticaria is defined as the occurrence of wheals and/or angioedema for a total duration of six weeks or more. Synonymous with "chronic urticaria" and "chronic idiopathic urticaria," it can be a debilitating condition with significant detriment on a patient's quality of life. This activity reviews the etiology, pathogenesis, and management of chronic spontaneous urticaria and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the proposed etiology of chronic spontaneous urticaria.</p></list-item><list-item><p>Summarize the pertinent points to explore in history in the evaluation of patients with chronic spontaneous urticaria.</p></list-item><list-item><p>Outline the pharmacologic and non-pharmacologic treatment options available for chronic spontaneous urticaria.</p></list-item><list-item><p>Discuss strategies for improving care coordination and communication among the interprofessional team to improve outcomes in the treatment of chronic spontaneous urticaria.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43025&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43025">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-43025.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chronic urticaria is a mast cell-mediated condition characterized by the recurrent occurrence of urticaria and/or angioedema.</p>
        <p>The current definitions and classification stratify urticaria according to time course and etiology:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Acute spontaneous urticaria</bold>: Spontaneous occurrence of wheals and/or angioedema for a total duration of fewer than six weeks.</p>
          </list-item>
          <list-item>
            <p><bold>Chronic spontaneous urticaria (CSU)</bold>: Spontaneous occurrence of wheals and/or angioedema for a total duration of six weeks or more. This is synonymous with "chronic urticaria" and "chronic idiopathic urticaria."</p>
          </list-item>
          <list-item>
            <p><bold>Chronic inducible urticaria (CIndU)</bold>: Occurrence of wheals for a total duration of six weeks or more, which is inducible by physical factors (<italic toggle="yes">e.g., touch, pressure extremes)</italic>. This is synonymous with "physical urticaria."<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43025.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of CSU is yet to be fully established. The prevailing hypothesis is that it relates to autoimmune dysfunction involving autoantibodies targeting IgE and/or IgE receptors to activate histamine release from basophils and mast cells. Up to 40% of patients with CSU demonstrate a positive autologous serum skin test (ASST), whereby the patient&#x02019;s serum injected into the dermis can induce urticaria.&#x000a0;One-third of patients with CSU also has a positive basophil histamine release assay (BHRA), which tests for anti-FceRIa (an IgE receptor) or anti-IgE autoantibodies in the serum.<xref ref-type="bibr" rid="article-43025.r2">[2]</xref><xref ref-type="bibr" rid="article-43025.r3">[3]</xref></p>
        <p>Further support is lent by the increased prevalence of autoimmune disorders amongst CSU patients. Of these, autoimmune hypothyroidism is the most common, observed in up to 9.8%. Other associated conditions include rheumatoid arthritis, systemic lupus erythematosus, Sjogren syndrome, celiac disease, and type-1 diabetes mellitus.<xref ref-type="bibr" rid="article-43025.r4">[4]</xref></p>
        <p>Infections by a variety of organisms have also been associated with CSU. These include bacteria (<italic toggle="yes">Helicobacter pylori, Streptococci, Staphylococci, Yersinia, Mycoplasma pneumoniae</italic>), virus (H<italic toggle="yes">epatitis virus, Norovirus, Parvovirus B19</italic>), and parasites (<italic toggle="yes">Giardia lamblia, Entamoeba spp., Anisakis simplex</italic>).&#x000a0;Causality remains unproven but may involve infection-mediated autoimmune response and molecular mimicry.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref><xref ref-type="bibr" rid="article-43025.r5">[5]</xref></p>
        <p>Foods and additives, while implicated in acute IgE-mediated food allergy, are rarely the cause of CSU.<xref ref-type="bibr" rid="article-43025.r6">[6]</xref></p>
        <p>Evidence for the association between malignancy and CSU is conflicting as different studies, including retrospective studies and systematic reviews, demonstrate varying results.<xref ref-type="bibr" rid="article-43025.r7">[7]</xref><xref ref-type="bibr" rid="article-43025.r8">[8]</xref></p>
      </sec>
      <sec id="article-43025.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of CSU is estimated at between 0.23% and 1.8% of the population in the U.S. and internationally. There is a strong female predilection, affecting women twice as often as men. Both children and adults are affected, although the prevalence is highest amongst those&#x000a0;40 to 60 years of age.<xref ref-type="bibr" rid="article-43025.r9">[9]</xref><xref ref-type="bibr" rid="article-43025.r10">[10]</xref>&#x000a0; &#x000a0;</p>
      </sec>
      <sec id="article-43025.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Urticaria and angioedema result from the activation of mast cells and basophils. Mast cell degranulation leads to the release of immune mediators. The primary mediator is histamine, which binds to H-receptors located on endothelial cells and sensory nerves. However, prostaglandin, leukotrienes, and a variety of cytokines and chemokines are also involved. Ultimately, this induces vasodilatation - increased permeability of vessels - and in turn, dermal edema and recruitment of inflammatory cells.</p>
        <p>Activation of mast cells can be divided into immunological and non-immunological processes.</p>
        <list list-type="bullet">
          <list-item>
            <p>Immunological activation is mediated by effectors of adaptive immunity binding receptors on mast cells. In type 1 hypersensitivity, crosslinking of allergen with IgE on sensitized mast cells leads to acute urticaria and anaphylaxis. In CSU, however, immunological activation of mast cells is thought to occur independently of allergen-IgE complexes and may involve IgG (type 2 hypersensitivity), circulating immune complexes (type 3 hypersensitivity), and T-cells (type 4 hypersensitivity).</p>
          </list-item>
          <list-item>
            <p>Non-immunological activation can be mediated by physical factors, as in CIndU, as well as food and drug molecules independent of adaptive immunity. In CSU, it may be that the threshold for activation by external stimuli is reduced.<xref ref-type="bibr" rid="article-43025.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43025.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histopathological features of urticaria include interstitial edema involving the upper and mid-dermis, mixed inflammatory perivascular infiltrates, and dilated venules and lymphatic vessels that permit leakage of serum into the surrounding tissue.</p>
        <p>Angioedema shares similar features, but they are observed deeper within the lower dermis and subcutaneous tissue.</p>
        <p>A biopsy of involved skin for histology is not a routine aspect of the workup for CSU; however, it can be considered when the rash is atypical. Leukocytoclasis and vasculitis are not seen with CSU and must prompt consideration of alternate diagnoses.<xref ref-type="bibr" rid="article-43025.r12">[12]</xref></p>
      </sec>
      <sec id="article-43025.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Urticaria is characterized by pruritic pink-to-red papules and plaques typically with central pallor. These can vary in size and shape as the plaques coalesce together. Urticaria is fleeting, and each wheal remains for fewer than 24 hours without any residual ecchymosis or pigmentation.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref> There may be a predilection for pressure-prone areas such as the waistline, axilla, and groin, but urticaria can generally affect any part of the skin.</p>
        <p>Secondary changes from scratching may be evident on examination of the skin, including excoriations, erosions, and hemorrhagic crust.</p>
        <p>Concurrent angioedema occurs in up to 40%, characterized by subcutaneous or submucosal edema affecting non-dependent areas, most commonly lips, peri-orbital, genitals, and extremities. Patients complain of discomfort or pain rather than pruritus. This may take longer to resolve - up to 72 hours - and is the primary manifestation of CSU in 10% of patients.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref><xref ref-type="bibr" rid="article-43025.r13">[13]</xref></p>
      </sec>
      <sec id="article-43025.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A thorough history aims to identify potential triggers and exacerbating factors and to exclude differential diagnoses. This should explore time course and clinical features of urticarial rash, associated angioedema, associated systemic and infective symptoms, personal or family history of allergies and autoimmune diseases, social and occupational history, induction by physical factors, recent newly administered medications, relationship to foods, and any exacerbating factors.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
        <p>If the patient cannot recall the time course of wheals, drawing around an individual lesion with a skin marking pen is useful to document resolution within 24 hours. Where history is unrevealing, an external cause is highly unlikely to be identified for patients with CSU.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
        <p>Routine diagnostic work-up for CSU is limited to blood tests for complete blood count and inflammatory markers (C-reactive protein and/or erythrocyte sedimentation rate), mostly to rule out other potential diseases. Eosinophilia may be associated with atopy and parasitic infection. Elevated inflammatory markers should prompt consideration of associated systemic disease. Further investigations without clinical suspicion, as guided by history, are unlikely to yield any additional diagnoses.<xref ref-type="bibr" rid="article-43025.r14">[14]</xref> Skin prick testing is not useful as CSU is rarely caused by type 1 allergy.<xref ref-type="bibr" rid="article-43025.r15">[15]</xref> The utility and interpretation of autologous serum skin test as a screen for autoantibodies to IgE and IgE receptors is an area of active research.<xref ref-type="bibr" rid="article-43025.r16">[16]</xref><xref ref-type="bibr" rid="article-43025.r17">[17]</xref></p>
        <p>A number of tools have been developed to assess disease activity (<italic toggle="yes">e.g., urticaria activity score)</italic>, disease control (<italic toggle="yes">e.g., urticaria control test</italic>), and impacts on quality of life (<italic toggle="yes">e.g., chronic urticaria quality of life index</italic>). Baseline assessments should be performed to help guide treatment decisions and monitor progress.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
      </sec>
      <sec id="article-43025.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The principles of management are to avoid exacerbating factors and to control symptoms as long as CSU persists. Pharmacological agents are directed at preventing mast cell degranulation and/or the effects of mast cell mediators released.</p>
        <p>Second-generation H1-antihistamines (<italic toggle="yes">e.g., cetirizine, loratadine, fexofenadine</italic>), taken regularly, are the first-line pharmacological treatment. The dose can be up-titrated to 4 times standard dose if symptoms remain at 2 to 4-week intervals. Due to anticholinergic properties and the adverse effect profile on the central nervous system, the routine use of first-generation H1-antihistamines is no longer recommended.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
        <p>The primary difference in treatment between CSU and CIndU is that as needed, treatment may be used for the latter if the patient knows his trigger and is able to plan by taking an H1-antihistamine approximately two hours before being exposed to it.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
        <p>Omalizumab is a monoclonal antibody with a high affinity for free IgE. Given as a subcutaneous injection, the standard dosing regimen is 300 mg every 4 weeks. This has been shown to be efficacious as a second-line adjunct therapy for CSU that is unresponsive to H1-antihistamines.<xref ref-type="bibr" rid="article-43025.r18">[18]</xref></p>
        <p>Ciclosporin is recommended as a third-line agent for CSU that remains refractory to the combination of H1-antihistamine and omalizumab. CSU is an off-label indication, and the dose and duration of ciclosporin should be minimized to avoid adverse events, including nephrotoxicity and hypertension.<xref ref-type="bibr" rid="article-43025.r19">[19]</xref></p>
        <p>For acute flares of CSU, short courses only of systemic corticosteroids may help alleviate symptom severity and reduce the duration of the flare.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref> Topical corticosteroids&#x000a0;do not have a role in CSU.<xref ref-type="bibr" rid="article-43025.r20">[20]</xref></p>
        <p>There is limited low-quality evidence for alternate therapeutic options, including leukotriene antagonists, dapsone, methotrexate, sulfasalazine, plasmapheresis, phototherapy, and intravenous immunoglobulin.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
      </sec>
      <sec id="article-43025.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Urticarial vasculitis is a small vessel vasculitis characterized by wheals that persist for greater than 24 hours, associated with pain rather than an itch, and which resolve with residual ecchymosis and/or pigmentation.</p>
          </list-item>
          <list-item>
            <p>Papular urticaria is a persistent insect bite reaction characterized by clusters of pruritic papules, often with a central punctum, which persists for days to weeks.</p>
          </list-item>
          <list-item>
            <p>Mastocytosis encompasses a group of disorders resulting from the accumulation of clonal populations of mast cells in the skin and other organs. Darier sign, where a wheal can be induced by rubbing the affected skin, is pathognomonic.</p>
          </list-item>
          <list-item>
            <p>Auto-inflammatory syndromes such as cryopyrin-associated periodic syndromes (CAPS) and Schnitzler syndrome may present with urticarial eruptions in association with fever, arthralgia, and systemic symptoms.</p>
          </list-item>
          <list-item>
            <p>C1-esterase inhibitor deficiency, either hereditary or acquired, should be considered in patients who present with isolated angioedema in the absence of an urticarial rash.</p>
          </list-item>
          <list-item>
            <p>Bullous pemphigoid is an immunobullous disease affecting the elderly. The pre-bullous phase is characterized by pruritus and urticarial plaques, which evolve to tense bullae.</p>
          </list-item>
          <list-item>
            <p>Anaphylaxis is a potentially life-threatening type I hypersensitivity reaction that most often presents acutely with cutaneous symptoms of hives and angioedema.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43025.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>CSU is typically self-limited, on average lasting 3 to 5 years.<xref ref-type="bibr" rid="article-43025.r21">[21]</xref> The reported rate of remission in the first 12 months is as high as 80%.<xref ref-type="bibr" rid="article-43025.r22">[22]</xref> However, up to 14% of patients may have persistent disease beyond 5 years.<xref ref-type="bibr" rid="article-43025.r23">[23]</xref> Factors that portend a prolonged disease course include thyroid autoimmunity and concurrent angioedema.<xref ref-type="bibr" rid="article-43025.r21">[21]</xref><xref ref-type="bibr" rid="article-43025.r24">[24]</xref></p>
      </sec>
      <sec id="article-43025.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The pruritus associated with CSU can be of significant detriment to the patient&#x02019;s quality of life and disrupt both activities of daily living and sleep.<xref ref-type="bibr" rid="article-43025.r25">[25]</xref>&#x000a0;Health status scores are also negatively affected by CSU.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref></p>
      </sec>
      <sec id="article-43025.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated on treatment goals. Regular use of H1-antihistamines confers better symptom control than as-needed administration.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref> Avoidance and understanding of factors that can further aggravate urticaria and pruritus also play an important role. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Drugs: Non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin can cause non-allergic hypersensitivity reactions in a subset of patients.<xref ref-type="bibr" rid="article-43025.r26">[26]</xref> Avoidance is recommended. &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Intercurrent illness: Urticaria may flare during bacterial and viral infections.</p>
          </list-item>
          <list-item>
            <p>Environmental factors: Tight clothing and heat (<italic toggle="yes">e.</italic><italic toggle="yes">g., </italic>hot showers) can often aggravate symptoms.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43025.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Disease duration of less than and more than 6 weeks separates acute from chronic spontaneous urticaria.</p>
          </list-item>
          <list-item>
            <p>If the patient cannot recall the time course of urticarial lesions, drawing around an individual lesion with a skin marking pen is useful to document resolution or migration within 24 hours.</p>
          </list-item>
          <list-item>
            <p>Where history is unrevealing, an external cause is highly unlikely to be identified for patients with chronic spontaneous urticaria. Diagnostic workup is unrevealing.</p>
          </list-item>
          <list-item>
            <p>Skin prick test is not indicated in chronic spontaneous urticaria.</p>
          </list-item>
          <list-item>
            <p>Wheals that are painful rather than pruritic, that persist for greater than 24 hours, and/or resolve with ecchymosis or pigmentation should prompt consideration of urticarial vasculitis.</p>
          </list-item>
          <list-item>
            <p>The recommended stepwise approach to management begins with second-generation H1-antihistamines, followed by the addition of omalizumab, and subsequently ciclosporin.</p>
          </list-item>
          <list-item>
            <p>The rate of spontaneous remission in the first twelve months is as high as 80%.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43025.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients in whom symptoms remain refractory to H1-antihistamines should be referred to a dermatologist and/or clinical immunologist for review and initiation of second and third-line therapeutic agents. CSU follows a fluctuant disease course and may resolve spontaneously. Accordingly, efficacy and need for continuation of treatment should be evaluated periodically at 3- to- 6-month intervals.<xref ref-type="bibr" rid="article-43025.r1">[1]</xref> The psychological burden of CSU should not be underestimated, and where appropriate, counseling and psychotherapy may enhance overall health outcomes.<xref ref-type="bibr" rid="article-43025.r27">[27]</xref></p>
      </sec>
      <sec id="article-43025.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43025&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43025">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/allergy/chronic-urticaria-chronic-hives/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=43025">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/43025/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=43025">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-43025.s17">
        <fig id="article-43025.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Urticaria Pigmentosa <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="urticaria__pigmentosa1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-43025.s18">
        <fig id="article-43025.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Urticaria, Upper Arm <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="urticaria" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-43025.s19">
        <fig id="article-43025.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Case of urticaria showing urticarial wheels Contributed by Ahmad Al Aboud, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_3329" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-43025.s20">
        <title>References</title>
        <ref id="article-43025.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuberbier</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aberer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Asero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abdul Latiff</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ballmer-Weber</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bindslev-Jensen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brzoza</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Buense Bedrikow</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Canonica</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Danilycheva</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Dressler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ensina</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Gim&#x000e9;nez-Arnau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Godse</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grattan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hebert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hide</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kapp</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katelaris</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kocat&#x000fc;rk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kulthanan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Larenas-Linnemann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Magerl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mathelier-Fusade</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meshkova</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Metz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nast</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nettis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oude-Elberink</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rosumeck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saini</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Borges</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmid-Grendelmeier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Staubach</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sussman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Toubi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vena</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Vestergaard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wedi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>M</given-names>
              </name>
              <collab>Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA&#x000b2;LEN, IAACI, IADVL, JDA, NVvA, MSAI, &#x000d6;GDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO</collab>
            </person-group>
            <article-title>The EAACI/GA&#x000b2;LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.</article-title>
            <source>Allergy</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>73</volume>
            <issue>7</issue>
            <fpage>1393</fpage>
            <page-range>1393-1414</page-range>
            <pub-id pub-id-type="pmid">29336054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Konstantinou</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Asero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knol</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raap</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schmid-Grendelmeier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Skov</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Grattan</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria.</article-title>
            <source>Allergy</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-36</page-range>
            <pub-id pub-id-type="pmid">23157716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sabroe</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Grattan</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Barr</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Kobza Black</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Greaves</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria.</article-title>
            <source>Br J Dermatol</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>140</volume>
            <issue>3</issue>
            <fpage>446</fpage>
            <page-range>446-52</page-range>
            <pub-id pub-id-type="pmid">10233264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Confino-Cohen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chodick</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shalev</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Leshno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kimhi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic urticaria and autoimmunity: associations found in a large population study.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2012</year>
            <month>May</month>
            <volume>129</volume>
            <issue>5</issue>
            <fpage>1307</fpage>
            <page-range>1307-13</page-range>
            <pub-id pub-id-type="pmid">22336078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wedi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Raap</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kapp</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic urticaria and infections.</article-title>
            <source>Curr Opin Allergy Clin Immunol</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>387</fpage>
            <page-range>387-96</page-range>
            <pub-id pub-id-type="pmid">15349038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria.</article-title>
            <source>Br J Dermatol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>166</volume>
            <issue>4</issue>
            <fpage>747</fpage>
            <page-range>747-52</page-range>
            <pub-id pub-id-type="pmid">22092280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindel&#x000f6;f</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sigurgeirsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wahlgren</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Eklund</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Chronic urticaria and cancer: an epidemiological study of 1155 patients.</article-title>
            <source>Br J Dermatol</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>123</volume>
            <issue>4</issue>
            <fpage>453</fpage>
            <page-range>453-6</page-range>
            <pub-id pub-id-type="pmid">2095176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>YT</given-names>
              </name>
            </person-group>
            <article-title>Cancer risk in patients with chronic urticaria: a population-based cohort study.</article-title>
            <source>Arch Dermatol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>148</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-8</page-range>
            <pub-id pub-id-type="pmid">22250240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wertenteil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Strunk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>152</fpage>
            <page-range>152-156</page-range>
            <pub-id pub-id-type="pmid">30872154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Jee</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Sheen</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>MY</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children.</article-title>
            <source>Allergy Asthma Immunol Res</source>
            <year>2017</year>
            <month>May</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>212</fpage>
            <page-range>212-219</page-range>
            <pub-id pub-id-type="pmid">28293927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hennino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>B&#x000e9;rard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guillot</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rozi&#x000e8;res</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nicolas</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of urticaria.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-11</page-range>
            <pub-id pub-id-type="pmid">16461989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baquerizo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Alikhan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>79</volume>
            <issue>4</issue>
            <fpage>599</fpage>
            <page-range>599-614</page-range>
            <pub-id pub-id-type="pmid">30241623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saini</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Chronic Spontaneous Urticaria: The Devil's Itch.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>1097</fpage>
            <page-range>1097-1106</page-range>
            <pub-id pub-id-type="pmid">30033911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kozel</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bossuyt</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Mekkes</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Bos</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>409</fpage>
            <page-range>409-16</page-range>
            <pub-id pub-id-type="pmid">12637921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augey</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gunera-Saad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bensaid</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nosbaum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nicolas</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Chronic spontaneous urticaria is not an allergic disease.</article-title>
            <source>Eur J Dermatol</source>
            <year>2011</year>
            <season>May-Jun</season>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>349</fpage>
            <page-range>349-53</page-range>
            <pub-id pub-id-type="pmid">21616748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Konstantinou</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Asero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sabroe</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Schmid-Grendelmeier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grattan</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria.</article-title>
            <source>Allergy</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>64</volume>
            <issue>9</issue>
            <fpage>1256</fpage>
            <page-range>1256-68</page-range>
            <pub-id pub-id-type="pmid">19650847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Sharkawy</surname>
                <given-names>REE</given-names>
              </name>
              <name>
                <surname>Abd-Elmaged</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Abdel-Wahed</surname>
                <given-names>SAE</given-names>
              </name>
            </person-group>
            <article-title>Pattern of chronic urticaria and value of autologous serum skin test in Sohag Province, Upper Egypt.</article-title>
            <source>Electron Physician</source>
            <year>2018</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>6781</fpage>
            <page-range>6781-6788</page-range>
            <pub-id pub-id-type="pmid">29997762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ledford</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ashby</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Canvin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zazzali</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Conner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Veith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kamath</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Staubach</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jakob</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stirling</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Kuna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ros&#x000e9;n</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>132</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-9</page-range>
            <pub-id pub-id-type="pmid">23810097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kulthanan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chaweekulrat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Komoltri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hunnangkul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tuchinda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chularojanamontri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>586</fpage>
            <page-range>586-599</page-range>
            <pub-id pub-id-type="pmid">28916431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellingsen</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Thestrup-Pedersen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chronic idiopathic urticaria with topical steroids. An open trial.</article-title>
            <source>Acta Derm Venereol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-4</page-range>
            <pub-id pub-id-type="pmid">8721491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Champion</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Urticaria and angio-oedema. A review of 554 patients.</article-title>
            <source>Br J Dermatol</source>
            <year>1969</year>
            <month>Aug</month>
            <volume>81</volume>
            <issue>8</issue>
            <fpage>588</fpage>
            <page-range>588-97</page-range>
            <pub-id pub-id-type="pmid">5801331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaig</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Olona</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz Lejarazu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Caballero</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Dom&#x000ed;nguez</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Echechipia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Abujeta</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Gonzalo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lleonart</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez C&#x000f3;cera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of urticaria in Spain.</article-title>
            <source>J Investig Allergol Clin Immunol</source>
            <year>2004</year>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-20</page-range>
            <pub-id pub-id-type="pmid">15552715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toubi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kessel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Avshovich</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bamberger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sabo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nusem</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Panasoff</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients.</article-title>
            <source>Allergy</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>869</fpage>
            <page-range>869-73</page-range>
            <pub-id pub-id-type="pmid">15230821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kulthanan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jiamton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thumpimukvatana</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pinkaew</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chronic idiopathic urticaria: prevalence and clinical course.</article-title>
            <source>J Dermatol</source>
            <year>2007</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>294</fpage>
            <page-range>294-301</page-range>
            <pub-id pub-id-type="pmid">17408437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Donnell</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Lawlor</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Greaves</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>The impact of chronic urticaria on the quality of life.</article-title>
            <source>Br J Dermatol</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>136</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-201</page-range>
            <pub-id pub-id-type="pmid">9068731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grattan</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Aspirin sensitivity and urticaria.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-7</page-range>
            <pub-id pub-id-type="pmid">12653694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43025.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berrino</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Voltolini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fiaschi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bignardi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Minale</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Troise</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maura</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Chronic urticaria: importance of a medical-psychological approach.</article-title>
            <source>Eur Ann Allergy Clin Immunol</source>
            <year>2006</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>149</fpage>
            <page-range>149-52</page-range>
            <pub-id pub-id-type="pmid">17058846</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
